Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Lab/Research institutions

地址:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road China (Mainland) Zhengzhou Henan

主营产品:

主要市场:North America South America Eastern Europe Southeast Asia Africa Oceania Mid

业务范围:we have excellent reasearchdevelopment team, first-class equipment. Can quickly create customer specified target of small molecules, and some of the macromolecular organic compounds.

注册资本: 1000000

公司规模:51 - 100People

成立年份:2013

法人代表:Deng Zhaoxi

Carl Wu

86-371-5521911186-13663865377

chiraldrug02@zzcpi.org

www.nkfine.com

Zhengzhou Institute of Chiral Pharmer Research Co.,Ltd,formed by Research Fellow of Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences and well-known professor of Tianjin university; We are committed to provide fine chemicals service for new drug development institutions in the world. Adhering to the "good reputation,high quality and low price service is the soul of a enterprise" business philosophy, our vision is to build a high efficient and high quality chemicals research and development platform, let our customers faster, better for new drug development, for human health, build first-class medicine.
Our services include custom synthesis, synthesis of amplification, outsourcing contracts, directories, reagents, etc.Laboratory built area of 1000 square meters, the existing research and development personnel more than 20 people, 10 and 20 litres, more than 50 litres of multi-function high and low pressure reaction kettle, able to complete levels g custom synthesis and kg technology development experiment.Existing 600 MB of nuclear magnetic resonance instrument, LCMS, Fourier infrared spectroscopy, liquid chromatography, differential thermal scanners and other advanced analytical instruments, can ensure the r&d project smoothly.Investors trading in chemicals for many years, the company have a mature market customers, able to provide the powerful market guarantees for research and development work.